Skip to search formSkip to main contentSkip to account menu

Victrelis

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

boceprevir
boceprevir 200 MG Oral Capsule [Victrelis]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Synthesis and Evaluation of New HCV NS3/4A Protease Inhibitors
The Hepatitis C virus infects an estimated 170 million people worldwide, and is the major cause of hepatitis, cirrhosis and liver… 
2012
2012
[Victrelis and Incivek against hepatitis C: some promising options].
2012
2012
Uso de boceprevir y telaprevir en pacientes con VHC (aspectos prácticos)
Review
2012
Review
2012
[Boceprevir (Victrelis), oral administration].
2012
2012
Victrelis et incivek guérir de l'hépatite C: des options thérapeutiques prometteuses.
2011
2011
Merck & Co. Joins Forces with Roche for Promotion of Victrelis™
Merck & Co. and Roche, two rivals in the hepatitis C virus (HCV) market, have joined forces in a broad, non-exclusive… 
Highly Cited
2011
Highly Cited
2011
New Merck and Vertex drugs raise standard of care in hepatitis C
2011
2011
Update in gastroenterology.
Chronic viral hepatitis B and C are a significant cause of chronic liver disease worldwide and still represent a pathology… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)